Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A southwest oncology group study
Georgiana K. Ellis, Stephanie Green, Susan Schulman, Charles A. Coltman Jr, Harry E. Hynes, Saul Rivkin, Robert B. LivingstonVolume:
68
Year:
1991
Language:
english
Pages:
6
DOI:
10.1002/1097-0142(19910901)68:53.0.co;2-n
File:
PDF, 549 KB
english, 1991